- •
The neurobehavioral effects of medications are relatively common and potentially life threatening.
- •
The nervous system can be affected whether the drug is targeted to treat a brain disorder or not.
- •
Sometimes the presentation follows a well-known pattern and the toxicity is relatively easy to diagnose.
- •
Other signs and symptoms may be subtle, not recognized by patients or caregivers, or ignored, leading to prolonged problems and risk of more serious complications.
Medicinal-Induced Behavior Disorders
Section snippets
Key points
Medication-induced behavioral side effects
In daily neurology practice, we see patients who present with behavioral changes that may not be explained by the primary diagnosis. Because some of our patients also have psychiatric diagnoses, the practitioner must have an open mind to find the cause of behavioral changes. When the secondary causes are being worked up, a complete list of the medications of each patient should be looked at closely, because medication side effects include behavioral changes. Some medications act as neurotoxins
Central nervous system toxicity
“That guy has delta MS.” The meaning of this phrase is easily understood by medical personnel from the lowest levels of training to the most senior clinicians. Unfortunately, however, as a diagnosis it is about as helpful as saying that a patient is sick. Recognition of the syndrome of CNS toxicity is relatively simple; determining the cause and therefore the appropriate management can be a challenge.
A change in mental status can be thought of as too excited (agitation, mania, hallucinosis,
Antihypertensive agent–induced behavioral side effects
Antihypertensive agents are among the most commonly prescribed medications to the general population. Among them, the commonly used β-adrenoreceptor antagonists (ß-blockers) have been reported to cause behavioral side effects such as drowsiness, fatigue, lethargy, sleep disorders, nightmares, depressive moods, and hallucinations. These undesirable actions indicate that ß-blockers affect not only peripheral autonomic activity, but also some CNS function. The various hypothesized centrally
Opioid-induced behavioral side effects
Chronic painful conditions are being increasingly treated with opioid medications in addition to their traditional role in the management of acute pain and cancer-related terminal pain. Psychological addiction, abuse, and diversion of these medications is a growing threat, because these agents are increasingly available to the general public. The commonly reported side effects of opioids include nausea, vomiting, constipation, dizziness, sedation, respiratory depression, tolerance, and physical
Antibiotic-induced behavioral side effects
Antibiotics are among the most commonly used medications in inpatient and outpatient settings. Various neuropsychiatric side effects are reported that may be dose dependent or idiosyncratic in nature.
Antiepileptic medication–induced behavioral side effects
The major categories of behavioral changes caused by antiepileptic drugs (AEDs) include mood alterations, withdrawal syndromes, intoxication and forced normalization (FN).56 Psychotropic effects can be either positive or negative depending on the drug used, the dosage, duration, efficacy, and the patient’s psychological predisposition. Owing to the variability of associated circumstances, the exact frequency of side effects is difficult to estimate. A case series of patients on AEDs who
Classic antiepileptic drugs
It is not unusual for epileptic patients (both children and adults) to develop depression after starting AED treatment.62, 63, 64 Children commonly develop a conduct disorder with features similar to attention deficit hyperactivity disorder. Hyperactivity is seen most commonly with phenobarbital. Developmentally delayed patients seem to be particularly susceptible to aggressive behavior and irritability when treated with barbiturates.
Steroid-induced behavioral side effects
Corticosteroid (CS) treatment is important in both acute (eg, asthma exacerbation) and chronic medical conditions (eg, systemic lupus erythematosus). Somatic side effects have been researched extensively and described widely, but less attention has been paid to neuropsychiatric adverse effects.
Adverse psychological side effects (APSE) from CS range from mild mood or cognitive deficits and emotional lability to severe psychotic symptoms, such as persecutory delusions or auditory hallucinations.97
Behavioral side effects of medications to treat Parkinson’s disease
The main classes of drugs used to treat Parkinson’s disease (PD) are levodopa, including carbidopa/levodopa combination pills, dopamine agonists (DAs), catechol-O-methyltransferase enzyme inhibitors, monoamine oxidase inhibitors, amantadine, and anticholinergics. The primary cause of behavioral disturbances in PD is dopamine replacement treatment with excessive or aberrant dopamine receptor stimulation. Dopamine has many important functions, including motor function, a role in the brain’s
Behavioral side effects of psychiatric medications
Individuals vary in their response to psychotropic and antidepressant medications, a critical problem when trying to manage psychotic disorders. This variability is multifactorial and may be owing to age, gender, comorbid medical conditions, other concurrent medications, and environmental factors. Genetic polymorphism, variations in pharmacokinetics, and pharmacodynamics also influence the treatment response. Cytochrome (CYP) enzymes, serotonin, and dopamine gene variants are known to
Behavioral side effects of human immunodeficiency virus and highly active antiretroviral therapy
Patients with human immunodeficiency virus (HIV) infection can suffer from various neuropsychiatric symptoms. They may be caused by the direct toxic effects of the virus on the CNS, comorbid psychiatric conditions, substance abuse, immunodeficiency leading to CNS opportunistic infections, activity of immune mediators, metabolic decompensation, and/or the side effects of the antiretroviral therapy. The discovery of antiretroviral drugs has changed the outlook of HIV in developed countries. It is
Chemotherapy-induced behavioral side effects
Although chemotherapeutic agents can achieve great success in the treatment of various cancers, some of these agents cause severe debilitating side effects that may warrant dose reduction or cessation of therapy. The commonly reported neuropsychiatric side effects of chemotherapy include fatigue, cognitive deficits, memory impairment, decreased attention span, deficiencies in executive functioning, and motivational deficits; they also cause neuropathy. These symptoms, which develop during
Immunotherapy-induced behavioral side effects
Commonly used immunotherapy medications like mycophenolate, interferon (INF)-α, INF-β, and interleukin (IL)-2 have all been shown to have neuropsychiatric side effects, especially depression.220
Conclusion
The neurobehavioral effects of medications are relatively common and potentially life threatening. The nervous system can be affected whether the drug is targeted to treat a brain disorder or not. Sometimes the presentation follows a well-known pattern and the toxicity is relatively easy to diagnose. Other signs and symptoms may be subtle, not recognized by patients or caregivers, or ignored leading to prolonged problems and risk of more serious complications.
The world’s population is aging,
References (240)
- et al.
Central nervous system toxicity
Emerg Med Clin North Am
(2014) - et al.
Guanethidine in the treatment of hypertension
Lancet
(1960) Opioid tolerance: the clinical perspective
Br J Anaesth
(1998)Opioids for chronic pain: taking stock
Pain
(2006)- et al.
Burst ketamine to reverse opioid tolerance in cancer pain
J Pain Symptom Manage
(2003) - et al.
Hyperalgesia: an emerging iatrogenic syndrome
J Pain Symptom Manage
(2003) - et al.
Opioids and abnormal pain perception: new evidence from a study of chronic opioid addicts and healthy subjects
Drug Alcohol Depend
(2006) New approaches to pain control in patients with cancer
Eur J Cancer
(1997)- et al.
Treatment of opioid-induced delirium with acetylcholinesterase inhibitors: a case report
J Pain Symptom Manage
(2004) Morphine sans Morpheus
Lancet
(1995)
Are opioid-dependent/tolerant patients impaired in driving related skills? A structured evidence based review
J Pain Symptom Manage
Piperacillin/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis
Am J Med Sci
Evidence for the involvement of GABA(A) receptor blockage in convulsions induced by cephalosporins
Neuropharmacology
Central nervous system Whipple’s disease: relapse during therapy with trimethoprim-sulfamethoxazole and remission with cefixime
Gastroenterology
Levofloxacin-induced delirium with psychotic features
Gen Hosp Psychiatry
Overrepresentation of epileptics in a consecutive series of suicide attempters seen at a children’s hospital, 1978–1983
J Am Acad Child Psychiatry
Valproate-induced hyperammonemia of renal origin
Biochem Pharmacol
Vigabatrin and behaviour disorders: a retrospective study
Epilepsy Res
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy trial group
Lancet
Tiagabine and non-convulsive status epilepticus
Seizure
The influence of comorbid depression on quality of life for people with epilepsy
Epilepsy Behav
Approach to diagnosis: occupational and environmental neurotoxicology
Toxic encephalopathy
Semin Neurol
CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action
Eur J Clin Pharmacol
Case report: severe neurologic reaction to ciprofloxacin
Can Fam Physician
Central nervous system side-effects with hydrophilic and lipophilic beta-blockers
Eur J Clin Pharmacol
CNS-related side-effects with metoprolol and atenolol
Eur J Clin Pharmacol
Mental effects of reserpine in man: a review
Clonidine in the treatment of severe hypertension
Med J Aust
Opioid complications and side effects
Pain Physician
Associative and behavioral tolerance to the analgesic effects of nicotine in rats: tail flick and paw-lick assays
Psychopharmacology (Berl)
Opiate addiction. VI: the effects of abrupt withdrawal followed by readministration of morphine in human addicts, with special reference to the composition of the blood, the circulation and the metabolism
Arch Intern Med
Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism
J Neurosci
Pharmacologic treatment of opioid-induced sedation in chronic pain
Ann Pharmacother
Opioid-induced bowel dysfunction: pathophysiology and potential new therapies
Drugs
Morphinelike arousal by methadone during sleep
Clin Pharmacol Ther
Adverse effects of opioids on the central nervous systems of palliative care patients
J Pain Palliat Care Pharmacother
Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis
J Antimicrob Chemother
Penicillinase and the convulsant action of penicillin
Neurology
The inexplicably suicidal patient
Current Psychiatry
Hoigne’s syndrome, kindling, and panic disorder
Depress Anxiety
Antibiotics: neuropsychiatric effects and psychotropic interactions
Harv Rev Psychiatry
Neurotoxicity associated with standard doses of piperacillin in an elderly patient with renal failure
Infection
Gentamicin neurotoxicity (polyneuropathy – encephalopathy)
Schweiz Med Wochenschr
Neurotoxic effects associated with antibiotic use: management considerations
Br J Clin Pharmacol
Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring
Ann Pharmacother
The neurotoxicity and safety of treatment with cefepime in patients with renal failure
Nephrol Dial Transplant
Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside
Eur J Clin Microbiol Infect Dis
Pharmacokinetics of cefepime in subjects with renal insufficiency
Clin Pharmacol Ther
Seizures in the critically ill: the role of imipenem
Epilepsia
Cited by (8)
Hoigné’s syndrome, an uncommon mimicker of anaphylaxis: Systematic literature review
2024, Journal of AutoimmunityFrontal Lobe Epilepsy: A Primer for Psychiatrists and a Systematic Review of Psychiatric Manifestations
2016, PsychosomaticsCitation Excerpt :Of note, certain anticonvulsants, such as valproic acid, carbamazepine, and lamotrigine have mood stabilizing effects and might be particularly helpful in some patients.51 On the contrary, others can worsen psychiatric symptoms, particularly barbiturates, levetiracetam, zonisamide, topiramate, and vigabatrin.52,53 Interictal mood changes do need to be treated with psychotropic medications.
Mitochondria and antibiotics: For good or for evil?
2021, Biomolecules
The authors have nothing to disclose.